Eli Lilly
Shares muted as investors digest US jobs data
European defence stocks dip amid hopes for Ukraine peace deal
Eli Lilly’s latest shot helped patients lose 29% of body weight in trials
Trial results are boost to US pharmaceutical company’s booming obesity business
What Taoiseach and Tánaiste told pharma sector amid lobbying efforts on EU reforms
Documents show Government assured the industry that Ireland had its back in Washington and Brussels
Ireland dodged a bullet this year. But there’s a caveat
Trouble for Simon Harris is that GDP figures don’t tend to cheer you up if you are juggling a long commute, childcare costs and soaring grocery bills
Fintan O’Toole: Ireland has two economies, one bourgeois, one proletarian. Both are broken
The bourgeoisification of the Irish workforce is a remarkable phenomenon
Garda probe on insider trading and Government response to AI
The best news, analysis and comment from The Irish Times business desk
Eli Lilly’s trillion-dollar climb exposes Europe’s absence from top ranks of stock markets
US accounts for 72.7% of the MSCI World Index, compared with just 2.6% for Europe’s biggest stock market, France
How a blockbuster weight-loss drug made Ireland the fastest-growing economy in the world
Unprecedented surge in Irish exports this year was almost entirely driven by shipments of drug ingredients for Eli Lilly
Eli Lilly’s blockbuster weight-loss drugs drive surge in Irish exports
Goods sent to US up 150% to €71bn as firms rushed to beat onset of tariffs
Settlement in case of former MD alleged to have taken company info and worked with rival
Dublin-headquartered Laydex Ltd, last month brought proceedings against former MD Gerard Callan
Dublin 6 the most expensive Eircode with house prices at almost €800,000
The best news, analysis and comment from The Irish Times business desk
Eli Lilly’s Dutch move offers Ireland hope
Trump administration pressure on Big Pharma to focus investment on the US has raised concerns in Europe, and specifically the Republic
Former MD agrees not to disclose information allegedly taken from company, court hears
Injunction sought restraining him from using data or disclosing or making it available to others
Trump’s bully boy tactics bringing Big Pharma to heel
Determination to cut prices for medicines in US may yet pile pressure on creaking European health budgets
‘Obesity medications may not make you thin or happy but they will improve your health’
GLP-1 drugs need to be reframed in the public mind as an essential medical treatment rather than ‘skinny jabs’, say practitioners
Big Pharma’s pullback from the UK could have serious side-effects for Ireland
Negotiations on new medicines pricing agreement comes as drug companies are under pressure to relocate investment back to US
Novo versus Lilly spotlights wider Europe-US corporate divide
US firms usually look leaner than their European counterparts when judged by revenue per employee
Project delivery PM Group spots slowdown in FDI wave into Ireland
Irish construction specialist’s fast-growing US business benefiting from reshoring of manufacturing operations under Trump
Weight-loss drugmaker Novo Nordisk to cut 9,000 jobs amid increased competition
The company’s shares have nearly halved since the start of the year and expects slower growth this year
Eli Lilly’s weight-loss breakthroughs face brutal investor scrutiny
Perfection was priced in, anything less provoked panic as shares were hit with worst one-day drop in 25 years
Trump-Putin summit boosts global stocks amid hopes of Ukraine ceasefire
Dublin’s Iseq moves 1% higher as banks and food stocks gain momentum
Eli Lilly obesity pill disappoints in trial, sending shares down 14%
Weight loss comes in at lower end of expectations and triggers stock boost for rival Novo Nordisk
‘A slow-moving car crash’: Novo Nordisk’s troubles keep mounting
Novo Nordisk has now lost two-thirds of its value in little over a year
In Ozempic’s home town they fear two things: a new set of tariffs, and a company in Kinsale
Pharmaceutical giants in Europe brace themselves for a tariffs fight that is likely still to come
Trump says tariffs on pharma and computer chip are likely by August 1st
Additional threat certain to alarm Government already working with EU to reduce impact of threatened 30% general tariff on exports to US
Is Big Pharma’s powerful US lobby shielding Ireland from the worst of Donald Trump’s tariffs?
The best-financed lobbyists in the United States are protecting the pharmaceutical sector, but that may change
Global stocks fluctuate as oil erases rally
Aviation stocks drop amid soaring jet fuel prices in Europe
Ousted Novo Nordisk CEO pays for investors’ inflated hopes
Investor expectations, it seems, are harder to manage than blood sugar
Ireland U-turns to oppose EU pharma reforms after intense lobbying
Pharmaceutical companies stepped up blitz to push Government to back industry position, lobbying logs show
Pharma bosses call for higher drug prices in EU to counter tariff threat
Novartis and Sanofi CEOs push for European benchmark against US prices
How Ireland’s tourist trap towns keep their buzz and business outside of the summer season
Keeping the shutters up and the lights on over the low season for tourism providers is a complex operation
This Irish town produces the world’s entire supply of Botox, but now Trump wants to bring it back to the US
Westport makes the world’s entire supply of the anti-wrinkle drug — now the feat is that production could move to the US
Big pharma sees positive side effects in Trump tariffs
Industry has used trade opportunity to hand European Commission a shopping list of asks
Lilly’s weight loss pill is a ‘landmark moment’ in the obesity fight
Prof Donal O’Shea hails breakthrough and says it may play key role in reshaping treatments
Weight loss drug Wegovy to cost around €220 a month as supplies go on market in Ireland
Weight loss drug is not yet approved for reimbursement under Drug Payment Scheme or for medical card patients
China woos CEOs of big global companies against backdrop of US tariffs
China Development Forum in Beijing hears that the country is willing to open its market further to foreign investment
Wegovy: The obesity ‘wonderdrug’ comes to Ireland, but it will cost you
Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now at least
Inside the pharma industry’s lobbying campaign to water down reforms
Pharma companies ‘disappointed’ in Government’s stance during EU negotiations
Ireland is the small country that has been doing a bit too well – and we’re right on Trump’s radar
The stellar Irish economic figures we are seeing are likely to be as good as it gets for now
If Trump carries through his tariff threats then chaos is coming
Even in the most transactional theory of Maganomics, bluffs on tariffs can only take the US president so far
Eli Lilly unveils $27bn US investment as corporate America seeks to woo Trump
CEO Dave Ricks credits Donald Trump with inspiring its push for US-based manufacturing
Insurers will not cover obesity drugs that will cost users €2,500-plus a year
Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately
Electricity network upgrades likely to see user bills rise
Seen & heard: Developers summoned; Xerotech on the brink; Glencore eyes Pallas Green sale; CRH invests in 3D; Mounjaro arrives; and O’Hara brewery talks
Europe worries as Wall Street pushes ahead on benign inflation data
Indices in Europe end last full trading week with losses as Washington again battles to stop government shutdown
Novo Nordisk shares tumble as weight-loss drug trial data disappoints
Obesity drug CagriSema misses goal of 25% body weight reduction
Lilly’s Zepbound tops Novo Nordisk’s Wegovy for weight loss in head-to-head trial
Companies competing for leadership in fast-growing market where supply continues to be an issue
Robert Kennedy jnr: Pharma investors brace for impact
Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination
Pharma packaging group West announces 330 jobs for Dublin
Announcement is first major investment by a US multinational following Trump victory in presidential election
Britain’s anti-obesity jab plan is the stuff of sci-fi
Drastic action is considered essential, but this is part of a wider strategy that represents a looming calamity for Stormont
Lilly turns to Ireland to produce two of the hottest therapy areas in medicine
Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy
Eli Lilly announces further $1bn investment in Limerick Alzheimer’s plant
US drug giant also formally opens $800m expansion of obesity and diabetes medicines plant in Cork
Eli Lilly to invest billions in weight loss drug site
Demand for the pharmaceutical company’s diabetes and weight loss injector pens is soaring
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices